Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$35.7M
-25.3% from 2023
Prescriptions
2.2M
$16.18 per claim
Patients
533K
200,671 prescribers
Total spending, 2024
$35.8M
$67.12 per patient
Medicare prescription drug plans paid $35.7M for Doxazosin Mesylate in 2024, for 2,209,560 prescriptions and refills to 532,558 patients (down 25.3% from 2023). The average cost per claim was $16.18.
Florida had the highest Medicare cost for Doxazosin Mesylate in 2024: $2.9M for 172,935 claims, followed by Puerto Rico ($2.7M).
Hector J Colombany Lorenzo, cardiology in Aguadilla, PR, had the highest Medicare cost for Doxazosin Mesylate in 2024: 2,239 claims costing $30K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Hector J Colombany Lorenzo Aguadilla, PR | Cardiology | 2,239 | 345 | $30K |
| Roberto H Gonzalez Sr. Aguada, PR | Internal Medicine | 448 | 118 | $16K |
| Gary D Goldberg |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 194,496 | 2,225,120 | 535,921 | $48.2M |
| 2023 | 196,713 | 2,179,456 | 528,737 | $47.9M |
| 2024 | 200,671 | 2,209,560 | 532,558 | $35.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Urology |
| 731 |
| 243 |
| $15K |
| Ildefonso Rivera Rivera Bayamon, PR | Cardiology | 464 | 138 | $15K |
| Carlos I Maldonado Juncos, PR | Internal Medicine | 604 | 164 | $15K |
| Alan R Puls Oklahoma City, OK | Interventional Cardiology | 615 | 181 | $15K |
| Jon D Leleux Lafayette, LA | Cardiology | 1,218 | 258 | $15K |
| Mark D Byron Jesup, GA | Urology | 914 | 268 | $14K |
| Angel J Miro-Diaz San Juan, PR | Internal Medicine | 525 | 146 | $14K |
| Jose A Padilla San Juan, PR | Cardiology | 441 | 141 | $14K |
| Robert O Morton Ada, OK | Psychiatry | 803 | 78 | $14K |
| Gerald Ukrainski Hammonton, NJ | Cardiology | 726 | 205 | $13K |
| Jamil Abouelhossen Fajardo, PR | Internal Medicine | 698 | 129 | $13K |
| Carlos A Muniz Molinero Sr. Aguada, PR | Internal Medicine | 813 | 176 | $12K |
| Steven L Richards Monroe, NJ | Urology | 664 | 187 | $12K |
| Fatima B Cintron-Rosa Humacao, PR | Nephrology | 472 | 142 | $12K |
| Kenneth E Wong Raceland, LA | Cardiology | 878 | 224 | $11K |
| Lance E Sullenberger Albany, NY | Cardiology | 459 | 156 | $11K |
| Christian E Rodriguez Rivera Caguas, PR | Internal Medicine | 324 | 120 | $11K |
| William C Sim Downey, CA | Internal Medicine | 562 | 119 | $11K |
| Charles N Glassman White Plains, NY | Urology | 559 | 147 | $10K |
| Marwan R Salfity Omaha, NE | Cardiology | 714 | 155 | $10K |
| Frank A McGrew Memphis, TN | Cardiology | 450 | 113 | $10K |
| Carlos M Martinez Rivera Mayaguez, PR | Endocrinology | 414 | 108 | $10K |
| Douglas Welsh Norfolk, NE | Interventional Cardiology | 380 | 111 | $10K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Apotex Corp | 1,302,000 | $21.2M |
| Upsher-Smith La | 274,182 | $4.5M |
| Teva USA TEVA | 232,310 | $4.0M |
| Zydus Pharmaceu ZYDUSLIFE.NS | 214,199 | $3.4M |
| Accord Healthca | 154,791 | $2.0M |
| Rising Pharm | 22,092 | $351K |
| Unichem Pharmac UNICHEMLAB.NS | 5,512 | $147K |
| Greenstone LLC. VTRS | 3,233 | $55K |
| Chartwell Rx Ll | 431 | $38K |
| Avet Pharmaceut | 648 | $10K |
| Major Pharmaceu | 603 | $8,284 |
| AHP | 13 | $152 |